Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

Finasteride was successfully synthesized from Pregnadienolone acetate.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Progesterone reduces spinal reflex activity by increasing certain GABA(A) receptor subtypes.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

The compound 4c effectively inhibits the enzyme linked to hair loss.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Antiandrogens block male hormones and are not safe during pregnancy.

A new compound that could treat various androgen-related conditions was created and analyzed.

The dutasteride nanoemulsion could improve hair loss treatment by enhancing drug penetration and retention in hair follicles.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.